Please contact our sales team for your Consulting and Customization queries/concerns at [email protected].
Market Analysis and Insights: Global Tumor Gene Test Service Market
The global Tumor Gene Test Service market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Tumor Gene Test Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Tumor Gene Test Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Tumor Gene Test Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Tumor Gene Test Service include Illumina, BGI Genomics Co.,Ltd., Agilent Technologies, Macrogen, Pacific Biosciences, 10x Genomics, QIAGEN, GEEWIZ and MACROGEN, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Tumor Gene Test Service market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Tumor Gene Test Service, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Tumor Gene Test Service, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Tumor Gene Test Service revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Tumor Gene Test Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Tumor Gene Test Service revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Illumina, BGI Genomics Co.,Ltd., Agilent Technologies, Macrogen, Pacific Biosciences, 10x Genomics, QIAGEN, GEEWIZ and MACROGEN, etc.
By Company
- Illumina
- BGI Genomics Co.,Ltd.
- Agilent Technologies
- Macrogen
- Pacific Biosciences
- 10x Genomics
- QIAGEN
- GEEWIZ
- MACROGEN
- Oxford Nanopore Technologies
Segment by Type
- Tumor Tissue
- Blood
Segment by Application
- Medical Institution
- Scientific Research Institutions
- Pharmaceutical Companies
- Individual User
By Region
- North America
- - United States
- - Canada
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- - Nordic Countries
- - Rest of Europe
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Australia
- - Rest of Asia
- Latin America
- - Mexico
- - Brazil
- - Rest of Latin America
- Middle East, Africa, and Latin America
- - Turkey
- - Saudi Arabia
- - UAE
- - Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Tumor Gene Test Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Gene Test Service companiesÂ’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tumor Gene Test Service revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Gene Test Service Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Tumor Tissue
1.2.3 Blood
1.3 Market by Application
1.3.1 Global Tumor Gene Test Service Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Medical Institution
1.3.3 Scientific Research Institutions
1.3.4 Pharmaceutical Companies
1.3.5 Individual User
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Gene Test Service Market Perspective (2018-2029)
2.2 Global Tumor Gene Test Service Growth Trends by Region
2.2.1 Tumor Gene Test Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Tumor Gene Test Service Historic Market Size by Region (2018-2023)
2.2.3 Tumor Gene Test Service Forecasted Market Size by Region (2024-2029)
2.3 Tumor Gene Test Service Market Dynamics
2.3.1 Tumor Gene Test Service Industry Trends
2.3.2 Tumor Gene Test Service Market Drivers
2.3.3 Tumor Gene Test Service Market Challenges
2.3.4 Tumor Gene Test Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Tumor Gene Test Service by Players
3.1.1 Global Tumor Gene Test Service Revenue by Players (2018-2023)
3.1.2 Global Tumor Gene Test Service Revenue Market Share by Players (2018-2023)
3.2 Global Tumor Gene Test Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Tumor Gene Test Service, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Tumor Gene Test Service Market Concentration Ratio
3.4.1 Global Tumor Gene Test Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Gene Test Service Revenue in 2022
3.5 Global Key Players of Tumor Gene Test Service Head office and Area Served
3.6 Global Key Players of Tumor Gene Test Service, Product and Application
3.7 Global Key Players of Tumor Gene Test Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Gene Test Service Breakdown Data by Type
4.1 Global Tumor Gene Test Service Historic Market Size by Type (2018-2023)
4.2 Global Tumor Gene Test Service Forecasted Market Size by Type (2024-2029)
5 Tumor Gene Test Service Breakdown Data by Application
5.1 Global Tumor Gene Test Service Historic Market Size by Application (2018-2023)
5.2 Global Tumor Gene Test Service Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Tumor Gene Test Service Market Size (2018-2029)
6.2 North America Tumor Gene Test Service Market Size by Type
6.2.1 North America Tumor Gene Test Service Market Size by Type (2018-2023)
6.2.2 North America Tumor Gene Test Service Market Size by Type (2024-2029)
6.2.3 North America Tumor Gene Test Service Market Share by Type (2018-2029)
6.3 North America Tumor Gene Test Service Market Size by Application
6.3.1 North America Tumor Gene Test Service Market Size by Application (2018-2023)
6.3.2 North America Tumor Gene Test Service Market Size by Application (2024-2029)
6.3.3 North America Tumor Gene Test Service Market Share by Application (2018-2029)
6.4 North America Tumor Gene Test Service Market Size by Country
6.4.1 North America Tumor Gene Test Service Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Tumor Gene Test Service Market Size by Country (2018-2023)
6.4.3 North America Tumor Gene Test Service Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Tumor Gene Test Service Market Size (2018-2029)
7.2 Europe Tumor Gene Test Service Market Size by Type
7.2.1 Europe Tumor Gene Test Service Market Size by Type (2018-2023)
7.2.2 Europe Tumor Gene Test Service Market Size by Type (2024-2029)
7.2.3 Europe Tumor Gene Test Service Market Share by Type (2018-2029)
7.3 Europe Tumor Gene Test Service Market Size by Application
7.3.1 Europe Tumor Gene Test Service Market Size by Application (2018-2023)
7.3.2 Europe Tumor Gene Test Service Market Size by Application (2024-2029)
7.3.3 Europe Tumor Gene Test Service Market Share by Application (2018-2029)
7.4 Europe Tumor Gene Test Service Market Size by Country
7.4.1 Europe Tumor Gene Test Service Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Tumor Gene Test Service Market Size by Country (2018-2023)
7.4.3 Europe Tumor Gene Test Service Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Tumor Gene Test Service Market Size (2018-2029)
8.2 China Tumor Gene Test Service Market Size by Type
8.2.1 China Tumor Gene Test Service Market Size by Type (2018-2023)
8.2.2 China Tumor Gene Test Service Market Size by Type (2024-2029)
8.2.3 China Tumor Gene Test Service Market Share by Type (2018-2029)
8.3 China Tumor Gene Test Service Market Size by Application
8.3.1 China Tumor Gene Test Service Market Size by Application (2018-2023)
8.3.2 China Tumor Gene Test Service Market Size by Application (2024-2029)
8.3.3 China Tumor Gene Test Service Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Tumor Gene Test Service Market Size (2018-2029)
9.2 Asia Tumor Gene Test Service Market Size by Type
9.2.1 Asia Tumor Gene Test Service Market Size by Type (2018-2023)
9.2.2 Asia Tumor Gene Test Service Market Size by Type (2024-2029)
9.2.3 Asia Tumor Gene Test Service Market Share by Type (2018-2029)
9.3 Asia Tumor Gene Test Service Market Size by Application
9.3.1 Asia Tumor Gene Test Service Market Size by Application (2018-2023)
9.3.2 Asia Tumor Gene Test Service Market Size by Application (2024-2029)
9.3.3 Asia Tumor Gene Test Service Market Share by Application (2018-2029)
9.4 Asia Tumor Gene Test Service Market Size by Region
9.4.1 Asia Tumor Gene Test Service Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Tumor Gene Test Service Market Size by Region (2018-2023)
9.4.3 Asia Tumor Gene Test Service Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Tumor Gene Test Service Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Tumor Gene Test Service Market Size by Type
10.2.1 Middle East, Africa, and Latin America Tumor Gene Test Service Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Tumor Gene Test Service Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Tumor Gene Test Service Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Tumor Gene Test Service Market Size by Application
10.3.1 Middle East, Africa, and Latin America Tumor Gene Test Service Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Tumor Gene Test Service Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Tumor Gene Test Service Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Tumor Gene Test Service Market Size by Country
10.4.1 Middle East, Africa, and Latin America Tumor Gene Test Service Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Tumor Gene Test Service Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Tumor Gene Test Service Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Tumor Gene Test Service Introduction
11.1.4 Illumina Revenue in Tumor Gene Test Service Business (2018-2023)
11.1.5 Illumina Recent Developments
11.2 BGI Genomics Co.,Ltd.
11.2.1 BGI Genomics Co.,Ltd. Company Details
11.2.2 BGI Genomics Co.,Ltd. Business Overview
11.2.3 BGI Genomics Co.,Ltd. Tumor Gene Test Service Introduction
11.2.4 BGI Genomics Co.,Ltd. Revenue in Tumor Gene Test Service Business (2018-2023)
11.2.5 BGI Genomics Co.,Ltd. Recent Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Tumor Gene Test Service Introduction
11.3.4 Agilent Technologies Revenue in Tumor Gene Test Service Business (2018-2023)
11.3.5 Agilent Technologies Recent Developments
11.4 Macrogen
11.4.1 Macrogen Company Details
11.4.2 Macrogen Business Overview
11.4.3 Macrogen Tumor Gene Test Service Introduction
11.4.4 Macrogen Revenue in Tumor Gene Test Service Business (2018-2023)
11.4.5 Macrogen Recent Developments
11.5 Pacific Biosciences
11.5.1 Pacific Biosciences Company Details
11.5.2 Pacific Biosciences Business Overview
11.5.3 Pacific Biosciences Tumor Gene Test Service Introduction
11.5.4 Pacific Biosciences Revenue in Tumor Gene Test Service Business (2018-2023)
11.5.5 Pacific Biosciences Recent Developments
11.6 10x Genomics
11.6.1 10x Genomics Company Details
11.6.2 10x Genomics Business Overview
11.6.3 10x Genomics Tumor Gene Test Service Introduction
11.6.4 10x Genomics Revenue in Tumor Gene Test Service Business (2018-2023)
11.6.5 10x Genomics Recent Developments
11.7 QIAGEN
11.7.1 QIAGEN Company Details
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN Tumor Gene Test Service Introduction
11.7.4 QIAGEN Revenue in Tumor Gene Test Service Business (2018-2023)
11.7.5 QIAGEN Recent Developments
11.8 GEEWIZ
11.8.1 GEEWIZ Company Details
11.8.2 GEEWIZ Business Overview
11.8.3 GEEWIZ Tumor Gene Test Service Introduction
11.8.4 GEEWIZ Revenue in Tumor Gene Test Service Business (2018-2023)
11.8.5 GEEWIZ Recent Developments
11.9 MACROGEN
11.9.1 MACROGEN Company Details
11.9.2 MACROGEN Business Overview
11.9.3 MACROGEN Tumor Gene Test Service Introduction
11.9.4 MACROGEN Revenue in Tumor Gene Test Service Business (2018-2023)
11.9.5 MACROGEN Recent Developments
11.10 Oxford Nanopore Technologies
11.10.1 Oxford Nanopore Technologies Company Details
11.10.2 Oxford Nanopore Technologies Business Overview
11.10.3 Oxford Nanopore Technologies Tumor Gene Test Service Introduction
11.10.4 Oxford Nanopore Technologies Revenue in Tumor Gene Test Service Business (2018-2023)
11.10.5 Oxford Nanopore Technologies Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Tumor Gene Test Service Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Tumor Tissue
Table 3. Key Players of Blood
Table 4. Global Tumor Gene Test Service Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Tumor Gene Test Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Tumor Gene Test Service Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Tumor Gene Test Service Market Share by Region (2018-2023)
Table 8. Global Tumor Gene Test Service Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Tumor Gene Test Service Market Share by Region (2024-2029)
Table 10. Tumor Gene Test Service Market Trends
Table 11. Tumor Gene Test Service Market Drivers
Table 12. Tumor Gene Test Service Market Challenges
Table 13. Tumor Gene Test Service Market Restraints
Table 14. Global Tumor Gene Test Service Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Tumor Gene Test Service Revenue Share by Players (2018-2023)
Table 16. Global Top Tumor Gene Test Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Gene Test Service as of 2022)
Table 17. Global Tumor Gene Test Service Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Tumor Gene Test Service Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Tumor Gene Test Service, Headquarters and Area Served
Table 20. Global Key Players of Tumor Gene Test Service, Product and Application
Table 21. Global Key Players of Tumor Gene Test Service, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Tumor Gene Test Service Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Tumor Gene Test Service Revenue Market Share by Type (2018-2023)
Table 25. Global Tumor Gene Test Service Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Tumor Gene Test Service Revenue Market Share by Type (2024-2029)
Table 27. Global Tumor Gene Test Service Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Tumor Gene Test Service Revenue Share by Application (2018-2023)
Table 29. Global Tumor Gene Test Service Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Tumor Gene Test Service Revenue Share by Application (2024-2029)
Table 31. North America Tumor Gene Test Service Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Tumor Gene Test Service Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Tumor Gene Test Service Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Tumor Gene Test Service Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Tumor Gene Test Service Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Tumor Gene Test Service Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Tumor Gene Test Service Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Tumor Gene Test Service Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Tumor Gene Test Service Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Tumor Gene Test Service Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Tumor Gene Test Service Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Tumor Gene Test Service Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Tumor Gene Test Service Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Tumor Gene Test Service Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Tumor Gene Test Service Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Tumor Gene Test Service Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Tumor Gene Test Service Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Tumor Gene Test Service Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Tumor Gene Test Service Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Tumor Gene Test Service Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Tumor Gene Test Service Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Tumor Gene Test Service Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Tumor Gene Test Service Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Tumor Gene Test Service Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Tumor Gene Test Service Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Tumor Gene Test Service Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Tumor Gene Test Service Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Tumor Gene Test Service Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Tumor Gene Test Service Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Tumor Gene Test Service Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Tumor Gene Test Service Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Tumor Gene Test Service Market Size by Country (2024-2029) & (US$ Million)
Table 63. Illumina Company Details
Table 64. Illumina Business Overview
Table 65. Illumina Tumor Gene Test Service Product
Table 66. Illumina Revenue in Tumor Gene Test Service Business (2018-2023) & (US$ Million)
Table 67. Illumina Recent Developments
Table 68. BGI Genomics Co.,Ltd. Company Details
Table 69. BGI Genomics Co.,Ltd. Business Overview
Table 70. BGI Genomics Co.,Ltd. Tumor Gene Test Service Product
Table 71. BGI Genomics Co.,Ltd. Revenue in Tumor Gene Test Service Business (2018-2023) & (US$ Million)
Table 72. BGI Genomics Co.,Ltd. Recent Developments
Table 73. Agilent Technologies Company Details
Table 74. Agilent Technologies Business Overview
Table 75. Agilent Technologies Tumor Gene Test Service Product
Table 76. Agilent Technologies Revenue in Tumor Gene Test Service Business (2018-2023) & (US$ Million)
Table 77. Agilent Technologies Recent Developments
Table 78. Macrogen Company Details
Table 79. Macrogen Business Overview
Table 80. Macrogen Tumor Gene Test Service Product
Table 81. Macrogen Revenue in Tumor Gene Test Service Business (2018-2023) & (US$ Million)
Table 82. Macrogen Recent Developments
Table 83. Pacific Biosciences Company Details
Table 84. Pacific Biosciences Business Overview
Table 85. Pacific Biosciences Tumor Gene Test Service Product
Table 86. Pacific Biosciences Revenue in Tumor Gene Test Service Business (2018-2023) & (US$ Million)
Table 87. Pacific Biosciences Recent Developments
Table 88. 10x Genomics Company Details
Table 89. 10x Genomics Business Overview
Table 90. 10x Genomics Tumor Gene Test Service Product
Table 91. 10x Genomics Revenue in Tumor Gene Test Service Business (2018-2023) & (US$ Million)
Table 92. 10x Genomics Recent Developments
Table 93. QIAGEN Company Details
Table 94. QIAGEN Business Overview
Table 95. QIAGEN Tumor Gene Test Service Product
Table 96. QIAGEN Revenue in Tumor Gene Test Service Business (2018-2023) & (US$ Million)
Table 97. QIAGEN Recent Developments
Table 98. GEEWIZ Company Details
Table 99. GEEWIZ Business Overview
Table 100. GEEWIZ Tumor Gene Test Service Product
Table 101. GEEWIZ Revenue in Tumor Gene Test Service Business (2018-2023) & (US$ Million)
Table 102. GEEWIZ Recent Developments
Table 103. MACROGEN Company Details
Table 104. MACROGEN Business Overview
Table 105. MACROGEN Tumor Gene Test Service Product
Table 106. MACROGEN Revenue in Tumor Gene Test Service Business (2018-2023) & (US$ Million)
Table 107. MACROGEN Recent Developments
Table 108. Oxford Nanopore Technologies Company Details
Table 109. Oxford Nanopore Technologies Business Overview
Table 110. Oxford Nanopore Technologies Tumor Gene Test Service Product
Table 111. Oxford Nanopore Technologies Revenue in Tumor Gene Test Service Business (2018-2023) & (US$ Million)
Table 112. Oxford Nanopore Technologies Recent Developments
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tumor Gene Test Service Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Tumor Gene Test Service Market Share by Type: 2022 VS 2029
Figure 3. Tumor Tissue Features
Figure 4. Blood Features
Figure 5. Global Tumor Gene Test Service Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Tumor Gene Test Service Market Share by Application: 2022 VS 2029
Figure 7. Medical Institution Case Studies
Figure 8. Scientific Research Institutions Case Studies
Figure 9. Pharmaceutical Companies Case Studies
Figure 10. Individual User Case Studies
Figure 11. Tumor Gene Test Service Report Years Considered
Figure 12. Global Tumor Gene Test Service Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Tumor Gene Test Service Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Tumor Gene Test Service Market Share by Region: 2022 VS 2029
Figure 15. Global Tumor Gene Test Service Market Share by Players in 2022
Figure 16. Global Top Tumor Gene Test Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Gene Test Service as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Tumor Gene Test Service Revenue in 2022
Figure 18. North America Tumor Gene Test Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Tumor Gene Test Service Market Share by Type (2018-2029)
Figure 20. North America Tumor Gene Test Service Market Share by Application (2018-2029)
Figure 21. North America Tumor Gene Test Service Market Share by Country (2018-2029)
Figure 22. United States Tumor Gene Test Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Tumor Gene Test Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Tumor Gene Test Service Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Tumor Gene Test Service Market Share by Type (2018-2029)
Figure 26. Europe Tumor Gene Test Service Market Share by Application (2018-2029)
Figure 27. Europe Tumor Gene Test Service Market Share by Country (2018-2029)
Figure 28. Germany Tumor Gene Test Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Tumor Gene Test Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Tumor Gene Test Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Tumor Gene Test Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Tumor Gene Test Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Tumor Gene Test Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Tumor Gene Test Service Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Tumor Gene Test Service Market Share by Type (2018-2029)
Figure 36. China Tumor Gene Test Service Market Share by Application (2018-2029)
Figure 37. Asia Tumor Gene Test Service Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Tumor Gene Test Service Market Share by Type (2018-2029)
Figure 39. Asia Tumor Gene Test Service Market Share by Application (2018-2029)
Figure 40. Asia Tumor Gene Test Service Market Share by Region (2018-2029)
Figure 41. Japan Tumor Gene Test Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Tumor Gene Test Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Tumor Gene Test Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Tumor Gene Test Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Tumor Gene Test Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Tumor Gene Test Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Tumor Gene Test Service Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Tumor Gene Test Service Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Tumor Gene Test Service Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Tumor Gene Test Service Market Share by Country (2018-2029)
Figure 51. Brazil Tumor Gene Test Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Tumor Gene Test Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Tumor Gene Test Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Tumor Gene Test Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Tumor Gene Test Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Tumor Gene Test Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Illumina Revenue Growth Rate in Tumor Gene Test Service Business (2018-2023)
Figure 58. BGI Genomics Co.,Ltd. Revenue Growth Rate in Tumor Gene Test Service Business (2018-2023)
Figure 59. Agilent Technologies Revenue Growth Rate in Tumor Gene Test Service Business (2018-2023)
Figure 60. Macrogen Revenue Growth Rate in Tumor Gene Test Service Business (2018-2023)
Figure 61. Pacific Biosciences Revenue Growth Rate in Tumor Gene Test Service Business (2018-2023)
Figure 62. 10x Genomics Revenue Growth Rate in Tumor Gene Test Service Business (2018-2023)
Figure 63. QIAGEN Revenue Growth Rate in Tumor Gene Test Service Business (2018-2023)
Figure 64. GEEWIZ Revenue Growth Rate in Tumor Gene Test Service Business (2018-2023)
Figure 65. MACROGEN Revenue Growth Rate in Tumor Gene Test Service Business (2018-2023)
Figure 66. Oxford Nanopore Technologies Revenue Growth Rate in Tumor Gene Test Service Business (2018-2023)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
|
Global Tumor Gene Test Service Market Research Report 2023
Highlights The global Tumor Gene Test Service market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukrai... |
|
Global Tumor Gene Test Service Market Research Report 2022
This report aims to provide a comprehensive presentation of the global market for Tumor Gene Test Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, a... |
